Inflammatory Bowel Disease
The IBD Clinical Trials Team conducts clinical trials of new drugs for patients with inflammatory bowel diseases, including Crohn’s Disease, Ulcerative Colitis and related conditions.
Do you have Chrohn's disease?
A post-marketing study of UPadacitinib evaluating speed of onset and durability of effectiveness for patients with moderate to severe Crohn’s disease for 3 years in the real-world
Trial status:
Active, not recruiting
Contact:
IBD Clinical Trials Team
A study looking at bowel healing for patients
Trial status:
Recruiting
Contact:
IBD Clinical Trials Team